Priority Date: 25.07.02 (US 20020398711P)

Quinoline derivatives as intermediates to mycobacterial inhibitors

  • Application ID: EP10154018
  • Status: No opposition filed within time limit

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
1 office
Technology Company
no operation time available
2 offices
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Janssen Pharmaceutica N.V. and J&J Patent Law Department are specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 233 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 25.07.2002 - Priority Date (US 20020398711P)
  • 30.03.2011 - Publication A1 (EP2301544)
  • 19.09.2012 - Publication B1 (EP2301544)